[250 Pages Report] Newly-released Laryngeal Mask Market analysis report by Future Market Insights shows that global sales of Laryngeal Mask Market in 2021 was held at US$ 656.4 Million. With 7.9%, the projected market growth during 2022 to 2032 is expected to be significantly higher than the historical growth.
Disposable Laryngeal Masks is expected to be the highest revenue generating segment, projected to grow at a CAGR of over 7.9% during 2022 to 2032.
| Attributes | Details |
|---|---|
| Laryngeal Mask Market CAGR (2022 to 2032) | 7.9% |
| Laryngeal Mask Market Size (2022) | US$ 656.4 million |
| Laryngeal Mask Market Size (2032) | US$ 1.5 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the Laryngeal Mask Market study conducted by Future Market Insights, a market research and competitive intelligence company, the market value of the Laryngeal Mask Market rose at a CAGR of roughly 7.1% from 2017 to 2021.
The market for laryngeal masks is expected to expand in conjunction with technical advances, such as the use of mechanical ventilation in suitably fasting patients while limiting the inspiratory forces imposed. When compared to first-generation LMAs, second-generation devices may reduce leak and restrict stomach insufflation. Moreover, throughout the projected period, increased demand for airway laryngeal masks are likely to drive the demand.
The lower cost per patient with the usage of the laryngeal masks contributes to their increasing popularity. Furthermore, the widespread availability of reusable laryngeal masks drives the revenue. Besides, their simplicity of usage and lesser requirement of sanitization, maintenance, less space consuming characteristic and being cost effective increases their utility.
In the coming years, the overwhelming numbers of surgical operations for the management of chronic disorders such as chronic bronchitis and asthma is predicted to fuel consumer demand for laryngeal mask. A significant increase in the worldwide frequency of respiratory ailments such as chronic obstructive pulmonary disease, and acute respiratory distress syndrome is expected to offer growth prospects over the projected timeframe.
Similarly, higher supply for airway ventilated laryngeal masks is expected to raise demand during the forecast period. Disposable medical equipment are in high demand in critical care units such as Intensive care unit (ICU) or trauma centers which has been consequently pushing the demand for laryngeal mask.
Furthermore, the introduction of low-cost laryngeal masks and growing market penetration efforts by key competitors in different regions, is expected to boost the revenue for laryngeal mask market. Furthermore, the increased frequency of chronic conditions requiring anaesthetic operations is pushing the demand for laryngeal masks.
As per the Healthcare Insurance Reciprocal of Canada (HIROC) and the Canadian Medical Protective Association (CMPA) medico-legal, about 1 Mn operations are conducted each year, drives the laryngeal mask demand.
Principal Consultant
Based on end-user, hospitals and clinics held the largest revenue share of over 60.3% in the market for laryngeal masks in 2020. Mask for the larynx airway is extremely useful in pre-hospital situations, for treating problematic airways, apart from the patients suffering from cardiac arrest.
Outside of the hospital, an LMA can be implanted for effective airway control until a permanent airway can be established. Due to the ease of accessibility and usage of attractive compensation schemes such as Medicare and Blue Cross Blue Shield, the segment will maintain its leading position during the predicted period. As a consequence, the worldwide market for laryngeal masks is predicted to grow at a fast pace in the coming years.
North America is likely to dominate the laryngeal mask market in the future years, owing to factors such as enhanced healthcare infrastructure and increase in the incidence of respiratory ailments like asthma. In addition, growing anaesthetic usage during surgeries is further driving the demand for laryngeal masks. Market growth is also attributed to standard regulatory regulations such as the compulsion to use masks during Covid in the region.
In contrast, the market in Asia Pacific is predicted to develop at the faster rate as compared to other regions over the forthcoming decade. The growth in revenue can be attributed to various factors including increase in the number of elderly population, and active involvement of industry participants like Medtronic Plc, Teleflex Inc., Intersurgical Ltd. towards increasing focus on the region's emerging countries.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States is a large global market for laryngeal masks. Over the forecast period, the laryngeal mask market in the United States is expected to witness significant boom. The country’s laryngeal mask market is fueled by growing elderly population and chronic illnesses.
During 2022-2032, disposable laryngeal masks market is expected to increase at a CAGR of about 7.9%. It provides patients with a pleasant airway while also removing the risk of disease transmission because it is not reused.
Furthermore, under nitrous oxide anaesthesia, laryngeal masks have a rather steady intracuff pressure. The disposable laryngeal mask is designed to be used as an alternative to a facemask for attaining and maintaining airway control in patients during normal and emergency anaesthetic treatments.
The decreased cost per patient associated with the usage of these masks can be attributable to their greater utilisation. Furthermore, owing to their cost effectiveness, their volume sales is on surge. These factors are likely to attract developing enterprises with limited capital resources to enter the market.
Revenue through Adults segment is expected to command significant revenue as well as a CAGR of approximately 8.1% in the Laryngeal Mask Market over the projection period. Because of the growing number of operations and the high incidence of chronic illnesses amongst adulthood, the segment is likely continue to grow at a constant CAGR.
Based on World Center for Environmental Research and Public Health, more than half of all Americans have chronic illness. The impact of chronic diseases on the laryngeal mask business in the near future is depicted to boost the market.
The COVID-19 pandemic is still harming many businesses' growth, and the outbreak's early signs are varied. Laryngeal masks were seen as a substitute to mask anesthetic and endotracheal intubation for surgical operations and the treatments of difficult airways.
Anaesthetists are more susceptible to infection when they perform aerosol-generating airway operations on a regular basis. This led in a slow adoption of laryngeal covers during the epidemic. Several anaesthetic essential management approaches had also been suggested due to the coronavirus epidemic. Some essential management approaches included safeguarding clinical staff and reducing aerosol emission.
The industry for laryngeal masks is being driven by a rise in medical procedures coupled with an expansion in disposable mask demands. Several mid-size and smaller enterprises are growing their market presence by offering laryngeal masks at cheaper pricing.
Some of the recent developments of key Laryngeal Mask providers are as follows:
Similarly, recent developments related to companies Laryngeal Mask services have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, Asia Pacific, Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE and Israel. |
| Key Market Segments Covered | Product Type, Patient, End Uses, Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global Laryngeal Mask Market is worth more than US$ 656.4 Mn at present.
Value of Laryngeal Mask Market are projected to increase at a CAGR of around 7.9% during 2022 – 2032.
Value of Laryngeal Mask Market increased at a CAGR of around 7.1% during 2017 – 2021.
The rising number of surgical operations, technical advancements, the prevalence of chronic respiratory disorders, and the ageing population are all propelling the laryngeal mask market forward.
The market for Laryngeal Mask Market in China is projected to expand at a CAGR of around 9.6% during 2022 – 2032.
While the market in South Korea is expected to grow at nearly 8.3%, the market in Japan is projected to register a CAGR of nearly 10.1% during 2022 - 2032.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Reusable Laryngeal Masks 5.3.2. Disposable Laryngeal Masks 5.3.3. Laparoscopic Diagnostic Procedures 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Patient 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Patient, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Patient, 2022-2032 6.3.1. Children 6.3.2. Adult 6.3.3. Geriatric 6.4. Y-o-Y Growth Trend Analysis By Patient, 2017-2021 6.5. Absolute $ Opportunity Analysis By Patient, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End Use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032 7.3.1. Hositals and Clinics 7.3.2. Ambulatiry Surgical Centers 7.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021 7.5. Absolute $ Opportunity Analysis By End Use, 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Patient 9.2.4. By End Use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Patient 9.3.4. By End Use 9.4. Key Takeaways 10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Patient 10.2.4. By End Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Patient 10.3.4. By End Use 10.4. Key Takeaways 11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Product Type 11.2.3. By Patient 11.2.4. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Patient 11.3.4. By End Use 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. India 12.2.1.5. Rest of Asia Pacific 12.2.2. By Product Type 12.2.3. By Patient 12.2.4. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Patient 12.3.4. By End Use 12.4. Key Takeaways 13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC 13.2.1.2. Rest of MEA 13.2.2. By Product Type 13.2.3. By Patient 13.2.4. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Patient 13.3.4. By End Use 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Patient 14.1.2.3. By End Use 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Patient 14.2.2.3. By End Use 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Patient 14.3.2.3. By End Use 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Patient 14.4.2.3. By End Use 14.5. Argentina 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Patient 14.5.2.3. By End Use 14.6. Germany 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Patient 14.6.2.3. By End Use 14.7. Italy 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Patient 14.7.2.3. By End Use 14.8. France 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Patient 14.8.2.3. By End Use 14.9. U.K. 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Patient 14.9.2.3. By End Use 14.10. Spain 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Patient 14.10.2.3. By End Use 14.11. Russia 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Patient 14.11.2.3. By End Use 14.12. BENELUX 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Patient 14.12.2.3. By End Use 14.13. China 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Patient 14.13.2.3. By End Use 14.14. Japan 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Patient 14.14.2.3. By End Use 14.15. South Korea 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Patient 14.15.2.3. By End Use 14.16. India 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Patient 14.16.2.3. By End Use 14.17. GCC Countries 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Patient 14.17.2.3. By End Use 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Patient 15.3.4. By End Use 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Ambu A/S 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segment 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.2. BLS Systems 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segment 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.3. Medtronic 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segment 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.4. Hsiner Co. Ltd. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segment 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.5. Thermo Fisher 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segment 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.6. Cardinal Health 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segment 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.7. Smiths Group plc 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segment 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.8. Intersurgical 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segment 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.9. Telefelx Incorporated 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segment 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.10. Ferno 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segment 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Laryngeal Mask Market
